Specify a stock or a cryptocurrency in the search bar to get a summary
Helius Medical Technologies Inc Class A
HSDTHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania. Address: 642 Newtown Yardley Road, Newtown, PA, United States, 18940
Analytics
WallStreet Target Price
92.47 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures HSDT
Dividend Analytics HSDT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HSDT
Stock Valuation HSDT
Financials HSDT
Results | 2019 | Dynamics |